Inhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling Pathway

• Hye Jung Ihn,

  Affiliation Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea

  ⨯
• Doohyun Lee,

  Affiliation College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Republic of Korea

  ⨯
• Taeho Lee,

  Affiliation College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Republic of Korea

  ⨯
• Sang-Hyun Kim,

  Affiliation Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea

  ⨯
• Hong-In Shin,

  Affiliation Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu, Republic of Korea

  ⨯
• Yong Chul Bae,

  Affiliation Department of Oral Anatomy and Neurobiology, School of Dentistry, Kyungpook National University, Daegu, Republic of Korea

  ⨯
• Jung Min Hong,

  Affiliation Skeletal Diseases Genome Research Centre, Kyungpook National University Hospital, Daegu, Republic of Korea

  ⨯
• Eui Kyun Park

  * E-mail: epark@knu.ac.kr

  Affiliation Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu, Republic of Korea

  ⨯